高糖抑制平滑肌细胞胶原合成参与糖尿病静脉病变发生

doi:10.3877/cma.j.issn.2095-5782.2020.01.013

目的

观察糖尿病大鼠大隐静脉（SV）的组织学改变，通过高糖处理静脉平滑肌细胞（SMCV）观察其活性及其Ⅰ型胶原（COL Ⅰ）、Ⅲ型胶原（COL Ⅲ）、基质金属蛋白酶2（MMP2）、基质金属蛋白酶组织抑制剂1(TIMP1)表达变化，探讨其表达异常的可能机制。

方法

用链脲佐菌素（STZ）腹腔注射构建糖尿病大鼠模型，对其SV进行HE染色、Masson染色观察其组织形态改变；体外培养SMCV，分别给与高糖、正常糖浓度培养，CCK8法检测其活性，RT-qPCR法、Western Blot（WB）法分别检测其细胞内COLⅠ、COLⅢ、MMP2、TIMP1 mRNA及蛋白表达，ELISA法检测细胞外COL Ⅰ、COLⅢ的表达。

结果

糖尿病大鼠SV管壁中膜变薄（P<0.05）、管腔面积增大（P>0.05）、胶原含量减少（P>0.05）。高糖刺激后SMCV细胞活性降低（P<0.05），细胞内COLⅠ mRNA无明显变化，COLⅢ mRNA表达下降（P<0.05），TIMP1 mRNA表达升高（P<0.05），MMP2 mRNA表达下降（P<0.05）。此外，高糖刺激后细胞内COLⅠ蛋白表达显著降低，COLⅢ蛋白表达无明显差异，TIMP1表达下降，MMP2表达升高，细胞外COLⅠ蛋白表达显著降低（P<0.05），COLⅢ表达降低但无统计学差异，COLⅠ/COLⅢ表达比例下降（P<0.05）。

结论

本研究证实糖尿病下肢静脉中膜变薄，管腔增大，胶原减少。高糖可能是通过转录后机制调控MMP2/TIMP1水平，影响SMCV细胞COLⅠ/COLⅢ的表达，抑制其胶原合成，参与静脉病变的发生。

关键词: 糖尿病, 慢性静脉疾病, 细胞外基质, 胶原

Objective

To determine the influence of diabetes on histological profile of lower limb veins, and to explore the mechanism of the effects of high-glucose medium in the viability and Collagen expression of venous smooth muscle cells (SMCV).

Methods

Diabetic rat model was established with intraperitoneal injection of streptozotocin. Hematoxylin-eosin (HE) and Masson staining were performed to observe the histological changes of great saphenous veins (SV). SMCVs were cultured in medium of high (DM group) or normal (NC group) levels of glucose, and the SMCVs viability was evaluated by cell counting kit-8 (CCK-8). The levels of TypeⅠ Collagen (COLⅠ), Type Ⅲ Collagen (COL Ⅲ), Metalloproteinase 2 (MMP2), Tissue inhibitor of metalloproteinase 1 (TIMP1) protein and mRNA expression in the cells were detected by Western Blot (WB) and Real-time quantitative Polymerase Chain Reaction (RT-qPCR). The contents of COLⅠ and COL Ⅲ in the cellular supernatant were detected using ELISA kit.

Results

Vein samples acquired from the diabetic rats showed lower medial thickness (P<0.05), larger luminal area (P>0.05) and lower collagen content (P>0.05). The viability of VSMCs was significantly declined in the DM group (P<0.05). There was no significant difference in the expression of COLⅠ mRNA between groups. The levels of COL Ⅲ mRNA was decreased in the DM group (P<0.05), followed by an ascending level of TIMP1 mRNA (P<0.05) and a declined level of MMP2 mRNA (P<0.05). WB analysis demonstrated that high-glucose treatment decreased the expression of COLⅠ and TIMP1 in SMCVs, accompanied with an increased expression of MMP2. ELISA showed that the expression of COLⅠ (P<0.05) and the ratio of COLⅠ / COL Ⅲ (P<0.05) in the cellular supernatant of DM group were also decreased.

Conclusions

The lower limb veins in diabetes presented histological changes as a lower medial thickness, larger luminal area and lower collagen content. High glucose treatment decreased the expression of COLⅠ and TIMP1 of SMCVs, and increased the expression of MMP2, which may suggest that high glucose inhibit the collagen expression of SMCVs via the regulation of MMP2/TIMP1 expression.

Key words: Diabetes mellitus, Chronic venous disease, Extracellular matrix, Collagen

图1 大鼠大隐静脉HE染色结果

表1 RT-qPCR引物序列

Gene	Sequence
COL1A1	GGCAACCTCAAGAAGTCCCT
	CCTGGTCTGGGGATACTCAC
COL3A1	AGGGCAGGGAACAACTGATG
	GGTCCCACATTGCACAAAGC
TIMP1	GGCACAGCTACAGGCTTTAC
	CCTGAGTCTCCCTAGAGCCAA
MMP2	ACCTTGACCAGAACACCATCGAG
	CAGGGTCCAGGTCAGGTGTGTA
β-actin	GGAGATTACTGCCCTGGCTCCTA
	GACTCATCGTACTCCTGCTTGCTG

表1 RT-qPCR引物序列

Gene	Sequence
COL1A1	GGCAACCTCAAGAAGTCCCT
	CCTGGTCTGGGGATACTCAC
COL3A1	AGGGCAGGGAACAACTGATG
	GGTCCCACATTGCACAAAGC
TIMP1	GGCACAGCTACAGGCTTTAC
	CCTGAGTCTCCCTAGAGCCAA
MMP2	ACCTTGACCAGAACACCATCGAG
	CAGGGTCCAGGTCAGGTGTGTA
β-actin	GGAGATTACTGCCCTGGCTCCTA
	GACTCATCGTACTCCTGCTTGCTG

图2 大鼠大隐静脉Masson染色结果

图3 SMCV a-SMA免疫荧光染色结果

图4 高糖处理后SMCV CCK8实验结果

图5 高糖培养72 h后SMCV细胞内mRNA检测结果（^*P<0.05)

图6 高糖培养后SMCV细胞内外相关蛋白表达情况

[1]	Mao W, Yip C W, Chen W. Complications of diabetes in China: health system and economic implications[J]. BMC Public Health, 2019, 19(1): 269. DOI:10.1186/s12889-019-6569-8.
[2]	Vuylsteke M E, Colman R, Thomis S, et al. An Epidemiological Survey of Venous Disease Among General Practitioner Attendees in Different Geographical Regions on the Globe: The Final Results of the Vein Consult Program[J]. Angiology, 2018, 69(9): 779-785. DOI:10.1177/0003319718759834.
[3]	Bergan J J, Schmid-Schonbein G W, Smith P D, et al. Chronic venous disease[J]. N Engl J Med, 2006,355(5): 488-498.DOI:10.1056/NEJMra055289.
[4]	Mani R, Yarde S, Edmonds M. Prevalence of deep venous incompetence and microvascular abnormalities in patients with diabetes mellitus[J]. Int J Low Extrem Wounds, 2011, 10(2): 75-79. DOI:10.1177/1534734611409372.
[5]	Fejfarova V, Roztocil K, Svedinkova A, et al. The relationship between chronic venous insufficiency and diabetes mellitus[J]. Int Angiol, 2017, 36(1): 90-91. DOI:10.23736/S0392-9590.16.03736-6.
[6]	Matic P, Jolic S, Tanaskovic S, et al. Chronic Venous Disease and Comorbidities[J]. Angiology, 2015, 66(6):539-544.DOI:10.1177/0003319714541988.
[7]	Purewal T S, Goss D E, Watkins P J, et al. Lower limb venous pressure in diabetic neuropathy[J]. Diabetes Care, 1995, 18(3): 377-381. DOI:10.2337/diacare.18.3.377.
[8]	Madi H A, Riches K, Warburton P, et al. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients[J]. Am J Physiol Cell Physiol, 2009, 297(5): C1307-C1317. DOI:10.1152/ajpcell.00608.2008.
[9]	Eble J A, Niland S. The extracellular matrix of blood vessels[J]. Curr Pharm Des, 2009, 15(12): 1385-1400.DOI:10.2174/138161209787846757.
[10]	Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry[J]. Circ Res, 2003, 92(8): 827-839. DOI:10.1161/01.RES.0000070112.80711.3D.
[11]	李培建，果海红，王玉乾．大鼠隐静脉注射方法探讨[J]．中国比较医学杂志，2003(05): 47.
[12]	沈芸，张琳，吴亚楠，等．老年2型糖尿病患者下肢静脉病变的研究[J]．中国糖尿病杂志，2011, 19(02): 111-113.
[13]	Berry C, Tardif J C, Bourassa M G. Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization[J]. J Am Coll Cardiol, 2007, 49(6) :643-656. DOI:10.1016/j.jacc.2006.09.045.
[14]	Kubal C, Srinivasan A K, Grayson A D, et al. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery[J]. Ann Thorac Surg, 2005, 79(5): 1570-1576. DOI:10.1016/j.athoracsur.2004.10.035.
[15]	Lorusso R, Pentiricci S, Raddino R, et al. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits[J]. Diabetes, 2003, 52(11): 2814-2820. DOI:10.2337/diabetes.52.11.2814.
[16]	Lazich I, Chang A, Watson S, et al. Morphometric and histological parameters in veins of diabetic patients undergoing brachiocephalic fistula placement[J]. Hemodial Int, 2015, 19(4) :490-498. DOI:10.1111/hdi.12289.
[17]	Chakraborty S K, Banu L A. Microscopic impacts of gestational diabetes mellitus on the umbilical cord[J]. Mymensingh Med J, 2013, 22(4): 755-760.
[18]	Riches K, Warburton P, O'Regan D J, et al. Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity[J]. Cardiovasc Revasc Med, 2014, 15(3): 141-148. DOI:10.1016/j.carrev.2014.02.005.
[19]	Riches K, Angelini T G, Mudhar G S, et al. Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm[J]. J Transl Med, 2013, 11: 208. DOI:10.1186/1479-5876-11-208.
[20]	Riches K, Alshanwani A R, Warburton P, et al. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function[J]. J Mol Cell Cardiol, 2014, 74: 240-250. DOI:10.1016/j.yjmcc.2014.05.018.
[21]	Sun Y, Kang L, Li J, et al. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes[J]. J Cell Mol Med, 2016, 20(10): 1945-1955. DOI:10.1111/jcmm.12886.
[22]	Ping S, Li Y, Liu S, et al. Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis[J]. PLoS One, 2015, 10(10): e141375. DOI:10.1371/journal.pone.0141375.

[1]	曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(07): 709-717.
[2]	王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3]	徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[4]	彭玲, 吴红, 宛仕勇, 陈斓, 叶子青, 周静. 胶原酶软膏联合水胶体敷料应用于深Ⅱ度烧伤创面治疗的效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 511-516.
[5]	宋勤琴, 李双汝, 李林, 杜鹃, 刘继松. 间充质干细胞源性外泌体在改善病理性瘢痕中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 550-553.
[6]	别瑶, 曹志斌, 辛静, 王健楠, 惠宗光. 应用基质血管成分细胞治疗糖尿病足溃疡的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 453-456.
[7]	孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[8]	傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[9]	梅杰, 徐瑞, 蔡芸, 朱一超. 纤维化对肿瘤浸润免疫细胞的影响——“硬冷肿瘤”的形成[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 257-263.
[10]	陈惠燕, 吴瑶, 黄宗炫, 卜歆, 王庆惠, 纪辉涛, 陈银珍, 赵虎. 肾间质纤维化中胶原/DDR2 信号活化对肾成纤维细胞增殖和迁移功能影响的实验研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 294-302.
[11]	严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[12]	周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
[13]	杜军霞, 赵小淋, 王浩然, 高志远, 王曼茜, 万楠熙, 张冬, 丁潇楠, 任琴琴, 段颖洁, 汤力, 朱晗玉. 2 型糖尿病的血液透析患者肠道微生物组学高通量测序分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 313-320.
[14]	周敏, 徐阳, 胡莹, 黄先凤. 维持性血液透析患者血清β-CTX、N-MID 和PICP 与冠状动脉钙化的关系及其诊断价值[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 256-260.
[15]	李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

High glucose inhibits the collagen expression of SMCVs in diabetes and participates in the development of diabetic venous disease

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

High glucose inhibits the collagen expression of SMCVs in diabetes and participates in the development of diabetic venous disease